Validation of Heart Rate Recovery as a Peri-operative Risk Measure
VERVE
1 other identifier
observational
84
1 country
3
Brief Summary
Is heart rate recovery after submaximal exercise (i.e. not to exhaustion) a valid risk measure for post-operative outcomes?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2022
Typical duration for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 10, 2022
CompletedFirst Submitted
Initial submission to the registry
September 27, 2022
CompletedFirst Posted
Study publicly available on registry
September 30, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2024
CompletedJuly 4, 2025
July 1, 2025
1.3 years
September 27, 2022
July 1, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Post-operative myocardial injury
Post-operative troponin over the 99th centile upper reference limit plus a 20% change (increase or decrease)
48 hours post-operatively
Secondary Outcomes (14)
Acute Kidney Injury
1 week post-operatively
Major adverse kidney events
30 days post-operatively
Cardiovascular complications
7 days post-operatively
Major adverse cardiac events
30 days post-operatively
Infective complications
7 days post-operatively
- +9 more secondary outcomes
Eligibility Criteria
95 patients 50 years or over undergoing intermediate/high risk surgery in the West of Scotland. Patients will be recruited from the Golden Jubilee National Hospital, Queen Elizabeth University Hospital, University Hospital Hairmyres or University Hospital Crosshouse.
You may qualify if:
- Provision of informed consent
- Age 50 years or over
- Able to walk unaided
- Planned elective intermediate/high risk surgery as defined by the ESC/ESA guidelines (i.e. \>1% risk of mortality)
You may not qualify if:
- Pregnancy
- Ongoing participation in any investigational research which could undermine the scientific basis of the study
- Presence of any of the American Thoracic Society's contraindications to exercise testing
- Previous intermediate/high risk surgery within three months prior to recruitment
- Previous participation in the VERVE study at any time
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Glasgowlead
- NHS National Waiting Times Centre Boardcollaborator
- NHS Greater Glasgow and Clydecollaborator
- NHS Ayrshire and Arrancollaborator
- NHS Lanarkshirecollaborator
Study Sites (3)
Golden Jubilee National Hospital
Clydebank, United Kingdom
University Hospital Hairmyres
East Kilbride, G75 8RG, United Kingdom
University Hospital, Crosshouse
Kilmarnock, KA2 0BE, United Kingdom
Study Officials
- PRINCIPAL INVESTIGATOR
Benjamin Shelley, MBChB, MD
National Waiting Times Centre Board
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Honorary Clinical Associate Professor/Consultant in Cardiothoracic Anaesthesia and Intensive Care
Study Record Dates
First Submitted
September 27, 2022
First Posted
September 30, 2022
Study Start
February 10, 2022
Primary Completion
June 1, 2023
Study Completion
August 1, 2024
Last Updated
July 4, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ANALYTIC CODE
We are keen to provide opportunities for data sharing. All requests for data sharing will be assessed individually and requests complying with the data governance regulations of the Sponsor and NHS R\&D will be honoured.